OPKO Health, Inc.
NASDAQ:OPKBiotechnology
+$0.01 today
- Market cap
- $1.25B
- Beta
- 1.49
- P/E (TTM)
- -5.1
- EPS (TTM)
- -$0.28
Volume 3.06M
Average 2.59M
OPK Total Debt
Short-term and long-term borrowings combined.
OPKO Health, Inc.NASDAQ: OPK
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt falls 19.5% from a year ago
Total debt stood at $396.93M at the end of Q1 FY2026, down 19.5% from a year earlier and down 8.5% from the prior quarter. Over 3 fiscal years it compounded at +12.4% a year.
Context
- Total debt amounted to 21.4% of total assets at the end of Q1 FY2026, down 1.8 pp from a year earlier.
- Total debt increased in 2 of the last 3 fiscal years.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -19.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 433.6M USD
- Year-over-year change
- -14.0%
- 4-year CAGR
- +14.2%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 433.6M | -14.0% |
| FY2024 | 2024-12-31 | 504.44M | +54.5% |
| FY2023 | 2023-12-31 | 326.56M | +6.9% |
| FY2022 | 2022-12-31 | 305.55M | +19.9% |
| FY2021 | 2021-12-31 | 254.76M | — |
Total Debt vs competitors
How OPK compares with its peers on the latest reported figures
- OPK's Mar 2026 total debt of $396.93M is the 3rd highest of the 11 companies compared; the peer median is $124.88M.
- Its year-over-year change of -19.5% is the lowest of 11, against a peer median of +26.8%.
- Total debt amounts to 21.4% of total assets for OPK, versus a peer median of 25.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $1.69B | +27.5% | +7.7% | 89.7% | |
| Jun 2026 | $448.37M | +8.9% | -8.2% | 33.2% | |
| Mar 2026 | $396.93M | -19.5% | +12.4% | 21.4% | |
| Jun 2026 | $238.49M | +21.6% | -21.7% | 9.0% | |
| Mar 2026 | $211.5M | +34.2% | +13.1% | 31.4% | |
BLLNBillionToOne, Inc. | Jun 2026 | $143.92M | +34.9% | — | 19.7% |
| Jun 2026 | $105.85M | +26.0% | +33.7% | 80.1% | |
| Mar 2026 | $38.78M | -12.7% | -6.4% | 11.9% | |
| Mar 2026 | $36.72M | +42.1% | +40.2% | 6.7% | |
| Mar 2026 | $25.35M | +8.2% | -9.9% | 48.8% | |
| Mar 2026 | $10.17M | +32.8% | -41.8% | 0.9% | |
| Peer median (excluding OPK) | $124.88M | +26.8% | -6.4% | 25.6% | |
Competitors are the stored peer set for OPK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 134.71M | 153.19M | 95.88M | 431.94M | 369.07M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 265.59M | 148.61M | 130.2M | 152.05M | 126.12M |
| Inventory | 86.5M | 74.06M | 65.7M | 56.8M | 65.82M |
| Other Current Assets | 321.19M | 6.25M | 7.67M | 10.71M | 8.17M |
| Total Current Assets | 823.01M | 394.53M | 309.48M | 662.09M | 581.88M |
| Property, Plant & Equipment (Net) | 123.96M | 121.6M | 143.52M | 124.14M | 120.86M |
| Goodwill | 520.6M | 595.85M | 598.26M | 529.25M | 484.29M |
| Intangible Assets | 911.88M | 1.02B | 935.28M | 811.61M | 516.28M |
| Long-term Investments | 10.71M | 28.05M | 16.08M | 54.58M | 14.17M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 9.55M | 8.71M | 9.08M | 18.54M | 214.47M |
| Total Non-current Assets | 1.58B | 1.77B | 1.7B | 1.54B | 1.35B |
| Total Assets | 2.4B | 2.17B | 2.01B | 2.2B | 1.93B |
| Account Payables | 82.04M | 66.99M | 69.68M | 47.07M | 41.1M |
| Short-term Debt | 14.69M | 36.59M | 27.29M | 15.02M | 22.86M |
| Tax Payables | 0 | 5.35M | 1.38M | 22.28M | 0 |
| Deferred Revenue | 258K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 74.1M | 40.24M | 56.92M | 41.09M | 82.72M |
| Total Current Liabilities | 330.01M | 213.48M | 200.05M | 193.1M | 146.68M |
| Long-term Debt | 190.16M | 219.47M | 222.03M | 422.18M | 370.53M |
| Deferred Tax Liabilities | 148.49M | 126.43M | 126.77M | 140.8M | 126.24M |
| Deferred Revenue (Non-current) | 208K | 138K | 7K | 6K | 0 |
| Other Non-current Liabilities | 9.71M | 11.05M | 12.2M | 25.77M | (19.67M) |
| Total Non-current Liabilities | 384.58M | 392.13M | 422.43M | 641.67M | 517.31M |
| Total Liabilities | 714.59M | 605.61M | 622.48M | 834.76M | 663.99M |
| Common Stock | 6.9M | 7.81M | 7.82M | 7.02M | 7.9M |
| Retained Earnings | (1.51B) | (1.82B) | (2.01B) | (2.07B) | (2.29B) |
| Accumulated OCI | (30.5M) | (43.32M) | (38.03M) | (56.13M) | (21.02M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.69B | 1.56B | 1.39B | 1.37B | 1.27B |
| Total Debt | 254.76M | 305.55M | 326.56M | 504.44M | 433.6M |
| Net Debt | 120.05M | 152.36M | 230.68M | 72.51M | 64.52M |
OPKO Health, Inc.
NASDAQ:OPK
Intrinsic Alpha fair value
Locked
Current Price
$1.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.